CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 103 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $136,000 | +72.2% | 25,664 | -3.1% | 0.00% | +100.0% |
| Q3 2020 | $79,000 | +97.5% | 26,496 | +156.3% | 0.00% | – |
| Q2 2019 | $40,000 | -68.3% | 10,336 | -58.1% | 0.00% | -100.0% |
| Q1 2019 | $126,000 | +21.2% | 24,645 | -7.6% | 0.00% | -66.7% |
| Q4 2017 | $104,000 | +258.6% | 26,658 | +132.2% | 0.00% | 0.0% |
| Q3 2017 | $29,000 | +16.0% | 11,480 | -10.8% | 0.00% | -40.0% |
| Q1 2017 | $25,000 | +108.3% | 12,863 | +10.9% | 0.01% | +25.0% |
| Q4 2016 | $12,000 | – | 11,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |